If you have been reading about tripeptide sequence and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-05-14. Where a claim depends on a specific study, the study is described rather than over-claimed.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and copper(II). The peptide sequence consists of glycine, histidine, and lysine, and its imidazole and amino groups provide binding sites for the metal ion. In the complex, copper is held through nitrogen donors from the histidine side chain, the N-terminal amine, and deprotonated amide nitrogens. The resulting compound is intensely blue and water-soluble. It occurs naturally in human plasma, saliva, and urine at low concentrations.
The peptide was first isolated from human albumin in 1973 by Loren Pickart, who later described its copper-binding behavior. Early work linked the complex to wound healing and tissue remodeling. Plasma levels of GHK decline with age, a pattern that stimulated interest in topical and supplemental applications. Researchers have reported that the tripeptide influences collagen synthesis, antioxidant defense, and inflammatory signaling in cell and animal models. Human clinical evidence remains limited and often relies on small studies.
Commercial products list GHK-Cu as copper tripeptide-1, a cosmetic ingredient. Formulators value its blue color and water solubility, which allow incorporation into serums, creams, and masks. Regulatory treatment varies: in the United States it appears in cosmetics, while some jurisdictions classify certain claims as drug-like. The compound is not an approved drug for any indication. Studies continue to examine its effects on skin, hair, and wound repair, but dosage, delivery, and long-term safety questions remain open.
GHK-Cu is a coordination complex formed from the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide binds copper through its histidine imidazole nitrogen, the terminal amino group, and the deprotonated amide nitrogen. This arrangement creates a square-planar or distorted geometry around the metal center, depending on pH and the presence of competing ligands. The complex occurs naturally in human plasma, saliva, and urine at low concentrations, and its sequence is conserved across many vertebrate species.
Discovery of GHK is generally attributed to work in the 1970s that isolated a plasma factor influencing liver cell behavior. Subsequent studies identified the copper-binding tripeptide and its ability to chelate copper with high affinity. Early reports linked the complex to wound healing and tissue remodeling in animal models. The free peptide and the copper-bound form have different properties, so the two are distinguished in the literature. Whether endogenous GHK-Cu serves a single primary physiological role remains an open question.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Copper(II) tripeptide complex | Contains glycyl-histidyl-lysine ligand |
| Peptide sequence | Gly-His-Lys | N-terminal glycine, C-terminal lysine |
| Molecular formula | C14H22CuN6O4 | Commonly cited for the 1:1 complex |
| Appearance | Blue to blue-violet solid | Color arises from copper d-d transitions |
| Solubility | Water-soluble | Also dissolves in some polar solvents |
Copper peptide solutions tend to resist degradation better than many free peptides, because the bound metal protects the N-terminus and reduces susceptibility to some peptidases. Backbone hydrolysis, oxidation of the histidine imidazole ring, and photochemical reactions remain the principal degradation routes. Aqueous solutions are generally most stable near neutral to mildly acidic pH, while strongly alkaline conditions accelerate hydrolysis. Light exposure is usually avoided, since both the peptide and the copper center can take part in photochemical processes. Stability data published by suppliers often describe short-term behavior rather than multi-year shelf life.
Identity and purity are commonly assessed by reversed-phase high-performance liquid chromatography, frequently paired with mass spectrometry to confirm the molecular ion. Copper content is measured separately, typically by inductively coupled plasma mass spectrometry or atomic absorption spectroscopy, because the chromatographic signal reports the peptide rather than the metal. Ultraviolet-visible spectroscopy provides a fast check on complex formation, since copper(II) peptide complexes absorb in the visible region. Elemental analysis and amino acid analysis are used less often but remain useful for reference standards. A gap between reported peptide purity and measured copper content is a recurring source of confusion.
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, a short sequence of three amino acids. The peptide was first isolated from human plasma in 1973 during research on factors that influence tissue repair in liver. Its ability to bind copper ions became a central point of interest because the metal changes the peptide's chemistry and its behaviour in laboratory systems. Today the compound appears in cosmetic formulations, cell-culture studies, and biochemistry literature under several names.
The peptide sequence places a histidine in the middle, and this residue dominates metal binding. Copper(II) coordinates through the imidazole nitrogen of histidine and the terminal amino group, forming a stable chelate ring system. Loss of the copper ion leaves the free tripeptide, which has different solubility and reactivity. This structural detail matters because assays that measure only the peptide backbone can miss whether copper is still bound to it.
Copper takes part in redox chemistry, and the same property that makes it useful in enzymes can generate reactive oxygen species when the ion is loosely bound. GHK chelates copper through imidazole, amino, and amide nitrogen donors, which reduces the amount of free copper in solution. Whether that chelation is protective, neutral, or harmful in a given tissue is not settled. Laboratory assays report both antioxidant and pro-oxidant behavior, depending on the conditions and the readout used.
Published work on GHK-Cu is dominated by in vitro experiments and small animal studies. Human trials tend to be short and small, with endpoints such as skin appearance rather than clinical outcomes. Review articles often summarize the same underlying laboratory findings, which can make the evidence base look broader than it is. Several basic questions remain open: the concentration of the intact complex in human tissue, the route by which it crosses the skin barrier, and whether effects seen in culture produce measurable changes in people.
"I am Shutruk-Nahhunte, son of Hallutush-Inshushinak, beloved servant of the god Inshushinak, king of Anshan and Susa, who has enlarged the kingdom, who takes care of the lands of Elam, the lord of the land of Elam. When the god Inshusinak gave me the order, I defeated Sippar. I took the stele of Naram-Sin and carried it off, bringing it to the land of Elam. For Inshushinak, my god, I set it as an offering."
December 12, 2005: Law concerning the treatment of repeat offenses. March 23, 2006: Law concerning equal pay between women and men. March 31, 2006: Law for equal opportunities. April 4, 2006: Law strengthening the prevention and repression of violence within couples or committed against minors. July 24, 2006: Law concerning immigration and integration. January 31, 2007: Law aiming to promote equal access for women and men to electoral mandates and elective functions (mandatory parity for municipalities with more than 3,500 inhabitants and in regional executives; alternates for general councilors, both of different genders; reduced public aid for a political party in case of non-compliance with parity for legislative election candidacies). This law will be followed by the laws of February 26 and July 23, 2008, concerning the facilitation of equal access between women and men to certain mandates and elected functions, as well as to social and professional responsibilities. March 5, 2007: Law concerning the prevention of delinquency. March 14, 2007: Creation of "3919," a national telephone number for victims and witnesses of domestic violence. April 13, 2007: Decree concerning the methods of calculation and sharing of family allowances in the case of alternating residence of children at each parent's home and amending the Social Security Code (second part: Decrees in the Council of State). August 1, 2007: Law authorizing the ratification of the Council of Europe Convention on Action against Trafficking in Human Beings.
Other measures included shifting the National Council of Traditional Peoples and Communities (CNPCT) from the Ministry of Human Rights and Citizenship to the Ministry of Environment and Climate Change, as well as the establishment of the "National Secretariat for Traditional Peoples and Communities and Sustainable Rural Development" under the same ministry.
Sources: en.wikipedia.org
=== Administrative history === The town was historically a chapelry in the ancient parish of Great Burstead. The Billericay Poor Law Union, created in 1835, gradually took on local government powers, becoming a rural sanitary district in 1872; this in turn became the Billericay Rural District in 1894, when a Great Burstead Parish Council was also created covering the parish. The rural district covered a large area stretching as far as Brentwood and Pitsea. In 1934, most of the rural district was reconstituted as Billericay Urban District and the parish councils within the area were abolished. Three years later, all the urban parishes within the district were united into a civil parish of Billericay. The urban district, but not the parish, was renamed Basildon in 1955, although the council continued to be based at the Town Hall and adjoining offices in Billericay until the early 1960s, when it moved into new premises in Basildon itself. In 1974, through enactment of the Local Government Act 1972, the Basildon Urban District was reconstituted as the modern Basildon district and the civil parish of Billericay was abolished, becoming an unparished area. A new civil parish of Billericay was established in 1996, this time just covering the town itself rather than the whole Basildon district.
ROS have been demonstrated to modify the visual appearance of fish. This potentially affects their behavior and ecology, such as their temperature control, their visual communication, their reproduction and survival. ROS are central to the photodegradation of organic pollutants in the atmosphere.
Prenatal cocaine exposure (PCE) may occur when a pregnant woman uses cocaine. Under the former FDA pregnancy category system, cocaine was classified as a Category C drug. Its potential to cause harm to the fetus is not fully known, so it should only be administered to pregnant women if clearly necessary. Cocaine can act as a teratogen, having various effects on the developing fetus. Some common teratogenic defects caused by cocaine include hydronephrosis, cleft palate, polydactyly, and down syndrome. Cocaine as a drug has a low molecular weight and high water and lipid solubility which enables it to cross the placenta and fetal blood-brain barrier. Because cocaine is able to pass through the placenta and enter the fetus, the fetus' circulation can be negatively affected. With restriction of fetal circulation, the development of organs in the fetus can be impacted, even resulting in intestines developing outside of the fetus' body. Cocaine use during pregnancy can also result in obstetric labor complications such as, placental abruption, preterm birth or delivery, uterine rupture, miscarriage, and stillbirth. Prenatal cocaine exposure may cause subtle cognitive deficits and lower the chance of above-average IQ by age 4, but supportive caregiving can significantly improve outcomes.
Sources: en.wikipedia.org
Early space food was primarily composed of bite-sized cubes, freeze-dried powders, and thick liquids stuffed in aluminum tubes. First used on the 3rd Mercury mission in 1962, US astronaut John Glenn was the first to eat directly from an aluminum tube, specifically applesauce. However the tubes were eventually discontinued as their design did not allow the food to be smelled or seen, and the texture also posed limitations on the variety of food that could be made available. Freeze-dried powders that could be re-hydrated were also available, as well as high-calorie bite sized cubes of food. These solutions had their own challenges, however over time, the powders were made easier to re-freeze, and the cubes were coated in gelatin to prevent crumbling on the equipment. With the introduction of the "spoon bowl," on the Apollo 8 mission, astronauts were able to open the contents of the package and eat the simple meal with a spoon. For lunch on Vostok 1 (1961), Yuri Gagarin ate from three 160 g (5.6 oz) toothpaste-type tubes, two of which contained servings of puréed meat and one which contained chocolate sauce. In August 1961, Soviet Cosmonaut Gherman Titov became the first human to experience space sickness on Vostok 2; he holds the record for being the first person to vomit in space. This event "heralded the need for space flight nutrition." John Glenn, as the first American to orbit Earth in 1962, was to experiment with eating in weightless conditions. Some experts had been concerned that weightlessness would impair swallowing.
Intracellular AMPARs are subsequently sorted for degradation by lysosomes or recycling to the cell membrane. For the latter, PICK1 and PKC can displace GRIP1 to return AMPARs to the surface, reversing the effects of endocytosis and LTD. when appropriate. Nevertheless, the highlighted calcium-dependent, dynamin-mediated mechanism above has been implicated as a key component of LTD. and as such may have applications to further behavioral research.
The uprising may have been significant for the organisational development and strategy of the UDF. Over the course of the first year of the uprising, an internal debate was settled in favour of the front taking on a more expansive role, which would go beyond campaign-based protest and opposition to the Tricameral Parliament. Thus in 1985, the front declared its proposal to move "from mobilisation to organisation" through a programme to strengthen its organisational structures and discipline, including through increased accountability and representation for local affiliates. Similarly, at the grassroots level, by 1986 there was a movement in many black townships to re-establish political discipline, including by persuading students to return to school and subjecting them to the authority of strong local civic associations which included representations for elders. Moreover, historians of South Africa's trade union movement often view the Vaal uprising as an inflection point in the politicisation (or re-politicisation) of the major trade unions. According to Eddie Webster, the November 1984 stay-away marked "the beginning of united mass action between organised labour, students and community organisations". The Charterist Congress of South African Trade Unions was founded in late 1985 and went on to play a crucial role in the Mass Democratic Movement.
Sources: en.wikipedia.org
GHK is the free tripeptide, while GHK-Cu includes a bound copper(II) ion. The copper complex is the form most often studied for skin and wound-related activity. The two names are sometimes used interchangeably in product labeling, but they refer to distinct chemical species.
Yes, it is found in human plasma, saliva, and urine. Its concentration in plasma tends to decrease with age. This natural presence is one reason researchers have investigated its role in tissue maintenance.
No, GHK-Cu is not an approved drug in major markets. It is widely used as a cosmetic ingredient, where it is listed under names such as copper tripeptide-1. Any therapeutic claims would require separate regulatory review.
GHK-Cu is a complex of the tripeptide glycyl-L-histidyl-L-lysine with copper(II). The peptide coordinates the metal through its histidine imidazole, terminal amino group, and amide nitrogen. It is studied in biochemistry and dermatological research.